我国东中西部地区医药制造企业研发投入的影响因素研究-中国药房.pdfVIP

我国东、中、西部地区医药制造企业研发投入的影响因素研究 ＊ # 郭丹丹 ，冯国忠（中国药科大学国际医药商学院，南京 211198） 中图分类号 R95 文献标志码 A 文章编号 1001-0408（2015）04-0436-04 DOI 10.6039/j.issn. 1001-0408.2015.04.02 摘 要 目的：为有效增加我国各地区医药制造企业的研发投入提供参考。方法：采用因子分析、线性回归方法，选取平均企业规 模、新产品销售收入占比、行业利润、研发人员占比、政府资金资助强度5个指标，构建东、中、西部地区医药制造企业研发投入的 影响因素评价体系，分别评价影响其研发投入的关键因素。结果与结论：影响东、中、西部地区医药制造企业研发投入的关键因素 各不相同。在3个模型中，政府资金资助强度因素指标系数均较大，表明该指标对各地区医药制造企业研发投入的影响均较显 著。研发人员占比、平均企业规模和研发人员占比、平均企业规模指标分别是东、中、西部地区研发投入的关键影响因素。建议各 地区医药制造企业抓住各自的关键影响因素，因地制宜，有效提高研发投入。 关键词 医药制造企业；地区；研发投入；影响因素；因子分析；线性回归 Study on Influential Factors of R ＆＆D Investment for Pharmaceutical Manufacturing Enterprises in East- ern ，Central and Western Regions of China GUO Dan-dan ，FENG Guo-zhong （School of International Pharmaceutical Business ，China Pharmaceutical Uni- versity ，Nanjing 211198，China ） ABSTRACT OBJECTIVE ：To provide reference for the promotion of RD investment for pharmaceutical manufacturing enter- prises in different regions of China. METHODS ：The factor analysis and linear regression method were adopted. Using average en- terprise scale ，the ratio of new product sale income ，industrial profits ，the proportion of RD staff ，government fund support as in- dex ，the evaluation system of influential factors of RD investment for pharmaceutical manufacturing enterprises was established in eastern ，central and western regions ；the effects of the system and key factor of RD investment both were evaluated. RESULTS CONCLUSIONS ：The key influential factors of RD investment are different in pharmaceutical manufacturing enterprises from eastern ，central and western regions. In three evaluation models ，the government fund support factors have large index coefficients ， which indicate the index show great influence on RD investment for pharmaceutical manufacturing enterprises in different regions. The proportion of RD staf